1. Home
  2. Astorg

Category: CDMO

Astorg agrees CordenPharma carve-out in deal said to exceed €2.5bn

French private equity group Astorg has agreed a buyout of drug contract development and manufacturing business CordenPharma in a deal reportedly worth more than €2.5bn. The post Astorg agrees CordenPharma carve-out in deal said to exceed

How investors can tap into the €100bn CDMO market

An estimated 25% of global drug production is in the hands of little-known players CDMOs, making them indispensable for industry, global healthcare systems and patients - not least during Covid. Navigating this terrain is tricky,

Private equity specialist Adragos Pharma brings in serial entrepreneur Otto Prange as general partner

Specialist private equity investor Adragos Pharma has brought in serial-entrepreneur and large family office head Otto Prange as general partner and investment committee chair.

NovaQuest Private Equity picks up contract development and manufacturing business CoreRx

Healthcare and life sciences investor NovaQuest Private Equity has bought contract development and manufacturing organization CoreRx.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.